[Activity of b-endorphin in patients with premature ovarian failure].

Ginekol Pol

Kliniki Ginekologii Operacyjnej, Akademii Medycznej, Szczecinie.

Published: May 1993

Examination of B-endorphin blood serum levels of 27 girls and young women with premature ovarian function depression was performed Patients were not pregnant before. The 54 young, regularly menstruating, healthy women composed the control group, who were divided into two groups according to the menstrual phase. Levels of B-endorphin were lower in examined group than in control one. High levels of B-endorphin were found at the patients with secondary diagnosed insensitive ovary syndrome. This fact suggest that examination of B-endorphin levels can be useful for clinical differentiation of insensitive ovary syndrome and premature ovarian function depression.

Download full-text PDF

Source

Publication Analysis

Top Keywords

premature ovarian
12
b-endorphin patients
8
examination b-endorphin
8
ovarian function
8
function depression
8
levels b-endorphin
8
insensitive ovary
8
ovary syndrome
8
[activity b-endorphin
4
patients premature
4

Similar Publications

The role of Anti-Müllerian hormone in women health.

Ginekol Pol

January 2025

Department of Clinical Dietetics, Faculty of Health Sciences, Medical University of Warsaw, Poland, Poland.

Anti-Müllerian hormone (AMH), also known as Müller duct inhibitory factor and primarily known for its role in sexual differentiation. In female fetuses, AMH production by granulosa cells begins around the 36th week of gestation and continues in women until menopause. It is becoming more significant in the endocrine and gynecological diagnosis of adult women.

View Article and Find Full Text PDF

Premature Ovarian Insufficiency refers to the premature decline in ovarian function before the age of 40, resulting in menstrual irregularities or complete cessation of menstruation, and affecting fertility. Widely used bisphenol compounds may have potential health effects, including premature ovarian insufficiency (POI). This study employs computational biology and bioinformatics to investigate the effects of bisphenols (BPs) on POI.

View Article and Find Full Text PDF

Female infertility, which affects 10-20% of couples worldwide, is a growing health concern in developing countries. It can be caused by multiple factors, including reproductive disorders, hormonal dysfunctions, congenital malformations and infections. In vitro and in vivo studies have shown that plant extracts regulate gonadotropin-releasing hormone, kisspeptin, and gonadotropin expression and/or secretion at the hypothalamic-pituitary level and modulate somatic and germ cells, such as steroidogenesis, proliferation, apoptosis, and oxidative stress at the ovarian level.

View Article and Find Full Text PDF

Background: Regenerative medicine researches have shown that mesenchymal stem cells (MSCs) may be an effective treatment method for premature ovarian insufficiency (POI). However, the efficacy of MSCs is still limited.

Purpose: This study aims to explain whether salidroside and MSCs combination is a therapeutic strategy to POI and to explore salidroside-enhanced MSCs inhibiting ferroptosis via Keap1/Nrf2/GPX4 signaling.

View Article and Find Full Text PDF

Truncated DAZL mutation reduces NANOS3 expression in primordial germ cells and leads to premature ovarian insufficiency.

Life Med

April 2024

The State Key Laboratory for Complex Severe and Rare Diseases, SXMU-Tsinghua Collaborative Innovation Center for Frontier Medicine, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!